Paul Schaffer
SVP of Research & DevelopmentDr. Paul Schaffer was Chief Technology Officer of Telix Pharmaceuticals Limited from April 6, 2025 to 2025. Dr. Paul Schaffer is SVP of Research & Development of Telix Pharmaceuticals Limited from 2025. Dr. Schaffer is Chief Technology Officer of ARTMS Products Inc. Dr. Schaffer is also Head of TRIUMF’s Life Sciences division. He joined TRIUMF in 2009 from the private sector where he worked at General Electric in upstate New York. He earned his Ph.D. in chemistry from McMaster University in 2003 and earned his B.Sc. with honours in chemistry and biochemistry from the University of British Columbia (UBC) in 1998. He is also an adjunct professor at Simon Fraser University’s Department of Chemistry and an assistant professor in the Department of Radiology at UBC.
Positions
- Company NameTelix Pharmaceuticals LimitedStock CodeTLXPositionSVP of Research & DevelopmentColleagues
- CPChristian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director
- DNDavid N. GillIndependent Non-Executive Chair of the Board
- DSDarren SmithGroup Chief Financial Officer
- DPDarren PattiGroup Chief Operating Officer
- DNDavid N. CadeGroup Chief Medical Officer
- MAMark Alexander NelsonIndependent Non-Executive Director
- JEJann Elizabeth SkinnerIndependent Non-Executive Director
- MEMarie E. McDonaldIndependent Non-Executive Director
